| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2012 | EP1628652B1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
| 07/11/2012 | EP1615622B1 Once daily formulations of doxycyclines |
| 07/11/2012 | EP1608309B1 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 07/11/2012 | EP1590360B1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 07/11/2012 | EP1505981B1 Utilization of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy |
| 07/11/2012 | EP1487778B1 Substituted 4-aminocyclohexanols |
| 07/11/2012 | EP1472224B1 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 07/11/2012 | EP1471056B1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/11/2012 | EP1470121B1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/11/2012 | EP1349560B1 Black tea extract for prevention of disease |
| 07/11/2012 | EP1282428B1 Biocompatible macromers |
| 07/11/2012 | EP1131052B1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 07/11/2012 | DE202012004679U1 Salbe Ointment |
| 07/11/2012 | CN202314492U 四物滴丸 Four things Dripping Pills |
| 07/11/2012 | CN202314491U 小儿镇静镇痛含服剂型 Pediatric sedation sublingual formulation |
| 07/11/2012 | CN202314488U 一种防过敏止痛贴膏 An anti-allergic and pain Plaster |
| 07/11/2012 | CN202314485U 糖尿病康复胶囊 Diabetes Rehabilitation Capsules |
| 07/11/2012 | CN202314484U Rosiglitazone maleate gastrointestinal mini-tablet capsule |
| 07/11/2012 | CN202314482U 布洛芬定时释药三层片 The timing of release of ibuprofen three-piece |
| 07/11/2012 | CN1934255B Combination therapy for the treatment of ocular neovascular disorders |
| 07/11/2012 | CN1900074B Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/11/2012 | CN1839847B Tizanidine hydrochloride oral disintegrating tablet and preparation method thereof |
| 07/11/2012 | CN1822880B Parasiticidal composition |
| 07/11/2012 | CN1805937B N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor. |
| 07/11/2012 | CN1805731B Composition and device for enhancing dosing efficiency |
| 07/11/2012 | CN1762381B Ophthalmic compositions containing galactomannan polymers and borate |
| 07/11/2012 | CN1688532B Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 07/11/2012 | CN1686139B Application of ketosolin in new type analgesic for treatig inflammatory pain |
| 07/11/2012 | CN1445224B Method for preparing arylaminopropanol |
| 07/11/2012 | CN102576016A Use of the SPARC microenvironment signature in the treatment of cancer |
| 07/11/2012 | CN102575252A Polynucleotides for multivalent RNA interference, compositions and methods of use thereof |
| 07/11/2012 | CN102575251A Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor |
| 07/11/2012 | CN102575250A Treatment and diagnosis of immune disorders |
| 07/11/2012 | CN102575236A Inhibition of histone acetyltransferases by CTK7A and methods thereof |
| 07/11/2012 | CN102575228A DNA-cell conjugates |
| 07/11/2012 | CN102574931A FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 07/11/2012 | CN102574890A Certain chemical entities, compositions, and methods |
| 07/11/2012 | CN102574879A Targetted drug delivery to the bone |
| 07/11/2012 | CN102574869A 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
| 07/11/2012 | CN102574866A Camptothecin derivatives |
| 07/11/2012 | CN102574865A Spirocyclic derivatives as histone deacetylase inhibitors |
| 07/11/2012 | CN102574864A Fused aminodihydropyrimidone derivatives |
| 07/11/2012 | CN102574863A Heterocyclic compounds as JANUS kinase inhibitors |
| 07/11/2012 | CN102574862A Method of preparing sitagliptin and intermediates used therein |
| 07/11/2012 | CN102574861A Methylpyrrolopyrimidinecarboxamides |
| 07/11/2012 | CN102574860A Pyrrolo[2,3-d]pyrimidine compounds |
| 07/11/2012 | CN102574858A Bicyclic heterocycles and their use as CCR2 receptor antagonists |
| 07/11/2012 | CN102574857A Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 07/11/2012 | CN102574856A Sitagliptin synthesis |
| 07/11/2012 | CN102574854A Macrocyclic integrase inhibitors |
| 07/11/2012 | CN102574853A Heterocyclic oxime compounds |
| 07/11/2012 | CN102574852A AKT inhibitors |
| 07/11/2012 | CN102574851A Fused heterocyclic ring derivative and use thereof |
| 07/11/2012 | CN102574847A Compounds and compositions as syk kinase inhibitors |
| 07/11/2012 | CN102574846A Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 07/11/2012 | CN102574845A 1h-imidazo[4,5-c]quinolinone derivatives |
| 07/11/2012 | CN102574844A Maleic acid salt and crystal thereof |
| 07/11/2012 | CN102574843A Fused ring analogues of anti-fibrotic agents |
| 07/11/2012 | CN102574842A Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 07/11/2012 | CN102574841A Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 07/11/2012 | CN102574840A R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
| 07/11/2012 | CN102574839A Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same |
| 07/11/2012 | CN102574837A Novel 5-fluorouracil derivative |
| 07/11/2012 | CN102574836A Aminopyrazole derivative |
| 07/11/2012 | CN102574835A Compounds useful for treating cancer |
| 07/11/2012 | CN102574834A Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof |
| 07/11/2012 | CN102574832A Substituted N-phenyl-1-(4-pyridinyl)-1H-pyrazol-3-amines |
| 07/11/2012 | CN102574830A Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 |
| 07/11/2012 | CN102574825A Thiazoles as cannabinoid receptor ligands |
| 07/11/2012 | CN102574824A Desferrithiocin polyether analogues and uses thereof |
| 07/11/2012 | CN102574823A Amide derivative |
| 07/11/2012 | CN102574822A Compounds as lysophosphatidic acid receptor antagonists |
| 07/11/2012 | CN102574818A Apaf-1 inhibitor compounds |
| 07/11/2012 | CN102574816A Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 07/11/2012 | CN102574812A New benzimidazole derivatives and their use as fxr agonists |
| 07/11/2012 | CN102574807A Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes |
| 07/11/2012 | CN102574805A Novel quinoline-hepcidine antagonists |
| 07/11/2012 | CN102574804A Quinolinyloxyphenylsulfonamides |
| 07/11/2012 | CN102574801A Substituted aminopropionic derivatives as neprilysin inhibitors |
| 07/11/2012 | CN102574799A Process for the manufacture of pharmaceutically active compounds |
| 07/11/2012 | CN102574793A (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors |
| 07/11/2012 | CN102574789A Pyrrolidinone carboxamide derivatives as chemerin-R ( CHEMR23 ) modulators |
| 07/11/2012 | CN102574788A Indole derivatives as crac modulators |
| 07/11/2012 | CN102574787A Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity |
| 07/11/2012 | CN102574786A Dihydroorotate dehydrogenase inhibitors |
| 07/11/2012 | CN102574785A Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators |
| 07/11/2012 | CN102574782A Substituted halophenoxybenzamide derivatives |
| 07/11/2012 | CN102574781A 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
| 07/11/2012 | CN102574778A Novel biphenyl and phenyl-pyridine amides |
| 07/11/2012 | CN102574025A System and method for extracting vitamin e from fatty acid distillates |
| 07/11/2012 | CN102573994A Novel bicyclic urea compounds |
| 07/11/2012 | CN102573993A Compounds for treatment of inflammation |
| 07/11/2012 | CN102573924A Drug composition for angiogenesis therapy |
| 07/11/2012 | CN102573911A Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders |
| 07/11/2012 | CN102573885A Composition having lipolysis-promoting effect |
| 07/11/2012 | CN102573882A Methods of treating bacterial infections using oritavancin |
| 07/11/2012 | CN102573859A Silver/polydiguanide complex, preparation method thereof, and antibacterial composition containing the same as an active ingredient |
| 07/11/2012 | CN102573857A Methods for preventing or treating sarcopenia and muscle atrophy in animals |
| 07/11/2012 | CN102573856A Method for the preparation of micro-RNAand its therapeutic application |
| 07/11/2012 | CN102573855A Modulation of axon degeneration |